Literature DB >> 25092599

A young patient with a family history of hypertension.

Aldo J Peixoto1.   

Abstract

The evaluation of causes of hypertension in young adults with a family history of hypertension needs to be methodical to identify potentially treatable causes. Renal- and renovascular imaging and measurement of plasma aldosterone and plasma renin activity are at the core of this evaluation in most patients. Pertinent aspects of hypertension in autosomal dominant polycystic kidney disease are discussed with a focus on the role of the endothelium in mediating early hypertension and a review of treatment strategies. Finally, the possibility that autosomal dominant polycystic kidney disease and primary aldosteronism are connected beyond coincidence is explored; evidence to support it is scant, although there is a likely role for aldosterone excess and the resultant hypokalemia in promoting cyst growth.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  aldosterone; genetic renal disease; hyperaldosteronism; hypertension; polycystic kidney disease

Mesh:

Substances:

Year:  2014        PMID: 25092599      PMCID: PMC4255397          DOI: 10.2215/CJN.02240314

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  61 in total

1.  Cortisone-induced renal changes in the rabbit: a microdissection study.

Authors:  T J BAXTER
Journal:  Br J Exp Pathol       Date:  1960-04

2.  Steroid-induced polycystic kidneys in the newborn rat.

Authors:  J F Crocker; A G Stewart; J M Sparling; M E Bruneau
Journal:  Am J Pathol       Date:  1976-02       Impact factor: 4.307

3.  Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease.

Authors:  Frederic F Rahbari-Oskoui; Dana C Miskulin; Marie C Hogan; Odicie Fielder; Vicente E Torres; James E Bost; Arlene Beth Chapman
Journal:  Blood Press Monit       Date:  2011-04       Impact factor: 1.444

4.  Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study.

Authors:  Christine Patch; Judith Charlton; Paul J Roderick; Martin C Gulliford
Journal:  Am J Kidney Dis       Date:  2011-04-02       Impact factor: 8.860

5.  Morphometric analysis of kidney hypertrophy in rats after chronic potassium depletion.

Authors:  M Elger; L Bankir; W Kriz
Journal:  Am J Physiol       Date:  1992-04

6.  Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function.

Authors:  Malene L Borresen; Dan Wang; Svend Strandgaard
Journal:  Am J Nephrol       Date:  2007-03-27       Impact factor: 3.754

7.  Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease.

Authors:  T C Li Kam Wa; A M Macnicol; M L Watson
Journal:  Nephrol Dial Transplant       Date:  1997-10       Impact factor: 5.992

8.  Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Jared J Grantham; Arlene B Chapman; Michal Mrug; Kyongtae T Bae; Bernard F King; Louis H Wetzel; Diego Martin; Mark E Lockhart; William M Bennett; Marva Moxey-Mims; Kaleab Z Abebe; Yan Lin; James E Bost
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-18       Impact factor: 8.237

Review 9.  Does kidney disease cause hypertension?

Authors:  Aldo J Peixoto; Marcelo Orias; Gary V Desir
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

Review 10.  Renovascular hypertension in children.

Authors:  Kjell Tullus; Eileen Brennan; George Hamilton; Rozanne Lord; Clare A McLaren; Stephen D Marks; Derek J Roebuck
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

View more
  3 in total

1.  Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report.

Authors:  Hiroyuki Hirai; Makoto Kanno; Tsuyoshi Watanabe; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

2.  Salt-deficient diet exacerbates cystogenesis in ARPKD via epithelial sodium channel (ENaC).

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Tengis S Pavlov; Elena Isaeva; Christine A Klemens; Jessica Johnson; Pengyuan Liu; Alison J Kriegel; Alexander Staruschenko
Journal:  EBioMedicine       Date:  2019-02-08       Impact factor: 11.205

3.  Hypokalemic Hypertension Leading to a Diagnosis of Autosomal Dominant Polycystic Kidney Disease.

Authors:  Wasawat Vutthikraivit; Montira Assanatham; Chutintorn Sriphrapradang
Journal:  Electrolyte Blood Press       Date:  2016-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.